← All companies

IMNN

Imunon, Inc.

IMNN Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.58

-0.02 -1.25%

Key statistics

from XBRL data in SEC filings

Market cap

$6.64M

Revenue (TTM)

$500K

Net income (TTM)

$14.3M

EPS (TTM)

$-4.52

P/E ratio

—

Dividend yield

—

Free cash flow

-$14.2M

Cash

$4.79M

Total assets

$8.02M

Gross margin

—

52-week range

$1.47 – $8.19

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jun 30, 2026 8-K Director or officer change; Shareholder vote results Jun 16, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change May 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Other events Mar 23, 2026 8-K Director or officer change Feb 5, 2026 8-K Director or officer change Jan 7, 2026 8-K Entered a material agreement; Other events Dec 31, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Delisting notice or listing-rule failure Aug 28, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Other events Jul 28, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure; Other events Jul 23, 2025 8-K Other events Jul 22, 2025 8-K Delisting notice or listing-rule failure; Director or officer change Jul 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jul 11, 2025 8-K Director or officer change Jun 13, 2025 8-K Other events Jun 9, 2025 8-K Delisting notice or listing-rule failure May 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events May 27, 2025 8-K Other events May 22, 2025 8-K Delisting notice or listing-rule failure May 20, 2025 8-K Entered a material agreement; Unregistered sale of equity May 13, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Director or officer change; Regulation FD disclosure Feb 10, 2025 8-K Delisting notice or listing-rule failure Nov 27, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Director or officer change; Regulation FD disclosure Oct 7, 2024 8-K Other events Sep 3, 2024